This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Authoring team

Treatment of seborrhoeic dermatitis generally involves the use of topical steroids and/or antifungals such as ketoconazole. Topical antifungal agents are the mainstay of treatment. Topical steroids are useful in the short term mainly to control erythema and itching (1)

The scalp (2)

  • ketoconazole 2% shampoo
    • initially use two to four times a week then once every two weeks for maintenance. an alternative is selenium sulphide shampoo
  • for itch and erythema - a topical steroid scalp application or mousse
  • for scale and crusts - olive oil for mild crusting. Sebco ® ointment massaged in and left on for two to four hours can be very useful for thicker scale / crust

Topical treatments for the skin (3)

  • topical ketoconazole cream - some patients find this causes too much skin irritation, in which case use either miconazole or clomitrazole cream
  • topical steroids can be added in for flare-ups but should only be used for one to two days at a time on facial skin
    • for adults who are affected by face and/or body seborrhoeic dermatitis, a mild topical corticosteroid cream, such as hydrocortisone 1% (or a combined imidazole and hydrocortisone preparation) can be considered to settle inflammation more quickly
  • if there are concerns about how much topical steroid is being used on the face consider the off-label use of topical calcineurin inhibitors eg pimecrolimus cream or tracrolimus ointment

More extensive or recalcitrant symptoms (4)

  • consider systemic itraconazole 100 mg per day for 14 days
  • if symptoms relapse frequently then consider six to eight week courses of a systemic tetracycline (off-label), which have an anti-inflammatory effect on the skin
  • consider HIV in patients with more severe symptoms (5)
  • patients responding inadequately to treatment should be referred to Secondary Care
    • in such cases a prolonged course of low dose isotretinoin, used off-label, may be considered

Ocular symptoms (6)

  • lid hygiene - clean eyelids using cotton wool soaked in cooled boiled water
  • artificial tears - should be applied liberally through the day if the eyes are dry or sore. If necessary a lubricating ointment, sometimes containing an antibiotic preparation may be used at night
  • as with rosacea, systemic tetracyclines given for six to eight weeks at a time can be useful for more troublesome symptoms such as blepharitis
    • erythromycin can be used in patients unable to take tetracyclines

Reference:

1. Kastarinen H, Oksanen T, Okokon EO, et al. Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database Syst Rev. 2014;(5):CD009446.

2. Schwartz JR, Bacon RA, Shah R, et al. Therapeutic efficacy of anti-dandruff shampoos: a randomized clinical trial comparing products based on potentiated zinc pyrithione and zinc pyrithione/climbazole. Int J Cosmet Sci. 2013;35:2013 Aug;35(4):381-7.

3. Apasrawirote W et al. Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis. J Med Assoc Thai. 2011 Jun;94(6):756-60.

4. Swinyer LJ, Decroix J, Langner, A. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis. Cutis. 2007 Jun;79(6):475-82.

5. Cortes-Correa C. et al. Facial Seborrheic Dermatitis in HIV-Seropositive Patients. Clin Cosmet Investig Dermatol. 2022; 15: 483–488.

6. Seborrhoeic eczema. Management of Ocular Symptoms. Primary Care Dermatology Society. Online 2024


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.